Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Innovation Occurs in Areas Without Bans

Yaeger 18 (Yaeger, Brianna. "When Innovation Exceeds Technological Capacity: A Moral Evaluation of CRISPR/Cas9’s Role in Genetic Engineering Research." (2018). https://utampa.dspacedirect.org/bitstream/handle/20.500.11868/407/Yaeger_RoyalRoad_2_2018_A.pdf?sequence=1. shARK.)

Incredibly, no one has disputed effective jurisdiction over the experimental use of the CRISPR system. Although officials have enacted countrywide bans in 40 nations, these restrictions are globally insignificant because the most progressive research in the human genetic engineering occurs in countries that lack any official ban—such as the United States and China (König 502-506). At present, valid concerns for genetic engineering with gene-editing tools such as CRISPR/Cas9 involve its democratization combined with its fallibility. The risks associated with these issues can manifest at any point in the near future, because legal interventions have yet to be made. In addition, the increasing use of CRISPR/Cas9 calls for legal intervention for the sake of impending issues, such as healthcare inequality and inevitably inspired nonmedical applications. The imminent problems contingent on CRISPR/Cas9’s popular use are anticipated to be palpable in the near future unless regulations are instituted for their effective prevention. This paper discusses some of the situational issues that the world is bound to deal with moving forward with the global democratization of CRISPR/Cas9.

Sign in to recut, update, or save this card.